English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  Modeling antibiotic treatment in hospitals: a systematic approach shows benefits of combination therapy over cycling, mixing, and mono-drug therapies

Tepekule, B., Uecker, H., Derungs, I., Frenoy, A., & Bonhoeffer, S. (2017). Modeling antibiotic treatment in hospitals: a systematic approach shows benefits of combination therapy over cycling, mixing, and mono-drug therapies. PLoS Computational Biology, 13(9): e1005745. doi:10.1371/journal.pcbi.1005745.

Item is

Files

show Files
hide Files
:
journal.pcbi.1005745.pdf (Publisher version), 4MB
Name:
journal.pcbi.1005745.pdf
Description:
-
OA-Status:
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-

Locators

show
hide
Description:
-
OA-Status:

Creators

show
hide
 Creators:
Tepekule, Burcu, Author
Uecker, Hildegard1, Author           
Derungs, Isabel, Author
Frenoy, Antoine, Author
Bonhoeffer, Sebastian, Author
Affiliations:
1External Organizations, ou_persistent22              

Content

show
hide
Free keywords: drug therapy; antibiotic resistance; linear discriminant analysis; superinfection; antimicrobial resistance; antibiotics; optimization; mathematical models
 Abstract: Author summary For life-threatening infections, antibiotics need to be administered as soon as possible. Because it takes time to acquire data about the disease causing bacteria, the immediate treatment is often empiric. In particular, there are three treatment strategies discussed in the field of empiric treatment: cycling, mixing, and combination therapy. Despite a number of clinical and theoretical studies, it still remains unclear which treatment strategy best prevents the emergence of resistance and why. To address this controversy, we present a mathematical model capturing both mono- and multi-drug therapies. We sample and analyze a large parameter space to assess the effect of parameters on treatment success, and determine which treatment strategy is the best under which circumstances. Using methods such as linear discriminant analysis and particle swarm optimisation, we find that combination therapy outperforms the other strategies by a large margin for most of the biologically relevant parameter space. We also show that the rate of de novo emergence of double resistance and the costs of resistance mutations are the most important parameters determining whether combination therapy succeeds over the others.

Details

show
hide
Language(s): eng - English
 Dates: 2017-03-202017-08-282017-09-152017-09
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.1371/journal.pcbi.1005745
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: PLoS Computational Biology
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: San Francisco, CA : Public Library of Science
Pages: - Volume / Issue: 13 (9) Sequence Number: e1005745 Start / End Page: - Identifier: ISSN: 1553-734X
CoNE: https://pure.mpg.de/cone/journals/resource/1000000000017180_1